Caplin Point Laboratories P/E Ratio
Caplin Point Laboratories P/E ratio. Caplin Point Laboratories (CAPLIPOINT) P/E ratio is 25.9 (High), EPS (TTM) ₹84.36, current price ₹2084.60 on NSE vs historical average P/E of 17.3 (80.0th percentile) — High - Growth expectations or overvalued. Also explore Caplin Point Laboratories share price performance to track price trends across different timeframes.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
CAPLIPOINT P/E Ratio — Valuation Signal & Historical Context
Caplin Point Laboratories P/E 25.9 vs historical average 17.3, range 7.15–31.12 — signal: Overvalued. Check CAPLIPOINT company valuation to track the company's total market size over time.
- Stock appears overvalued with PE of 25.9, suggesting caution for new investments
- Current PE is 49.7% above historical average
- Trading at discount to sector average PE of 52.3
Caplin Point Laboratories P/E Ratio Historical Trend
CAPLIPOINT annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 25.9 vs historical average 17.3. For live price, revenue and the complete fundamental profile, see CAPLIPOINT screener.
CAPLIPOINT Historical P/E Ratio — EPS, Year-End Price & Valuation
Caplin Point Laboratories annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 31.12 | 80.73 | ₹2512.30 | NSE | High |
| 2024 | 19.99 | 67.83 | ₹1355.95 | NSE | Moderate |
| 2023 | 12.56 | 57.64 | ₹723.70 | NSE | Low |
| 2022 | 18.73 | 46.59 | ₹872.45 | NSE | Moderate |
| 2021 | 13.31 | 37.96 | ₹505.10 | NSE | Low |
| 2020 | 9.92 | 29.71 | ₹294.60 | NSE | Low |
| 2019 | 13.41 | 28.54 | ₹382.70 | NSE | Low |
| 2018 | 28.84 | 21.98 | ₹634.00 | NSE | High |
| 2017 | 17.99 | 18.9 | ₹340.05 | NSE | Moderate |
| 2016 | 7.15 | 38.86 | ₹277.68 | NSE | Low |
CAPLIPOINT vs Healthcare Peers — P/E Ratio Comparison
Caplin Point Laboratories P/E 25.9 vs Healthcare average 52.3, median 29.6 — range 2.0–733.0.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.0 | ₹72 | Low |
| Brooks Laboratories | BROOKS | 2.6 | ₹206 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.3 | ₹54 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.1 | ₹6,355 | Low |
| Dipna Pharmachem | DPL | 4.5 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 4.7 | ₹82 | Low |
| Royal Sense | ROYAL | 4.8 | ₹34 | Low |
| Star Imaging And Path Lab | STARIMAGIN | 5.3 | ₹110 | Low |
| Kabra Drugs | KABRADG | 6.3 | ₹49 | Low |